Objectives: To describe the maternal and fetal outcome in pre-gestational diabetes mellitus and gestational diabetes mellitus and to compare with that of non-diabetic pregnancies.
Introduction
Diabetes mellitus (DM) is a group of metabolic disorders characterized by a state of hyperglycaemia resulting from defects in insulin secretion, insulin action or both. 1 Gestational diabetes mellitus (GDM) is defined as glucose intolerance that is first detected during pregnancy. 2 Prevalence of GDM is increasing and varies between 1 to 14% depending up on population screened, screening methods and diagnostic criteria used. 3, 4 Type 2 diabetes is also increasing and increased number of cases are being detected at an earlier age. Pregnancy and DM affect each other adversely. Pregnancy implies increased nutritional demands and increasing insulin resistance resulting from action of placental hormones accentuates the risk of maternal morbidity and fetal mortality. Diabetic patients have poor pregnancy outcome in terms of Caesarean section, gestational hypertension, macrosomia, neonatal hypoglycaemia, respiratory distress syndrome (RDS), pre-term delivery and neonatal intensive care unit (NICU) admissions. 5, 6 GDM, though not to the same extent for DM, affects pregnancy outcome adversely. [7] [8] [9] [10] This study was designed to evaluate the pregnancy outcome of patients with pre-gestational diabetes and GDM, and compare with those of non-diabetic pregnant patients. A total of 150 pregnant patients were evaluated during this period. They were divided in 3 groups; patients with pre-gestational diabetes were in Group A, patients with GDM were in Group B and non-diabetic patients were in Group C. Patients with pre-gestational diabetes and GDM requiring insulin in 3 rd trimester were included in the study and patients on medical nutrition therapy were excluded.The study protocol was approved by Bangladesh College of Physicians and Surgeons (BCPS) and informed consent was taken from every patient before enrolment for the study.
Materials and Methods

Results
In this cross-sectional study, a total of 150 pregnant patients were evaluated. Fifty patient had pre-gestational diabetes mellitus (Group A), 50 had GDM (Group B) and 50 patients were non-diabetic (Group C). Age distribution of the study subjects are shown in Table I .
Table I
Age distribution of the study subjects
7 (14) 6 ( Table II .
Post-partum haemorrhage (PPH) was the most common maternal complication in all three groups and other complications are shown in Table III . Birth weight of the babies were normal in 48 (96%), 46 (92%) and 44 (88%) in group A, B and C respectively.
Common neonatal complications were respiratory distress syndrome (RDS) and hyperbilirubinaemia and hypoglycaemia in diabetic and GDM cases (group A and B) (Table IV) . Six (12.8%), 7 (14.3%) and 6 (30%) of neonates with complications in group A, B and C respectively required neonatal care unit admission.
The insulin requirement of pre-gestational diabetes patients and patients with GDM are presented in 
Discussion
Good glycaemic control by medical nutrition therapy (MNT) and insulin, when required, along with proper ante-natal checkup can make diabetic and GDM pregnancies as safe as non-diabetic pregnancy. Generally maternal and neonatal complications are much more common in diabetic and GDM preganacies.
The rate of Caesarean section was more in pregestational diabetic group and past history of Caesarean section was the commonest indication in all 3 groups. Jerin J et al. in a study found that 82% of GDM cases required Caesarean section. 11 Low birth weight was not a major concern in this current study.
PPH was the commonest maternal complication in this study, which was more in pre-gestational pregnant group. PPH was less common in previous study. 11 Wound infection was also more in pre-pregnancy diabetes group.
Neonatal complications were also much more common in pre-pregnancy diabetes and GDM groups specially RDS and hyperbilirubinaemia. Neonatal hypoglycaemia was more in pre-gestational diabetes group than GDM group. Several studies showed that good glycaemic control reduces neonatal complications. 9, 10, [12] [13] [14] [15] Our study had some limitations. Limited number of patients were included in this study. Status of glycaemic control and accordingly pregnancy outcomes were not evaluated. In many cases neonatal follow up was not possible beyond 72 hours.
From the current study it can be concluded that maternal and fetal outcome in pre-gestational diabetes and GDM is worse in comparison with non-diabetic pregnancies. It can further be concluded that neonatal hyperbilirubinaemia and hypoglycaemia were more in pre-gestational diabetes group than GDM group.
